Do you want to read an article? Please log in or register.
Moderate and Severe Acute Respiratory Distress Syndrome: Hemodynamic and Cardiac Effects of an Open Lung Strategy With Recruitment Maneuver Analyzed Using Echocardiography
Related content
RECOMMENDED
ARDS
Lung Ultrasound Predicts Histological Lung Injury in a Neonatal Model of Acute Respiratory Distress Syndrome
★ 2
Recommended by
Dr Martin Frey, Faculty Member
Pediatr Pulmonol.
Elsayed YN, Hinton M, Ruth Graham M, Dakshinamurti S
doi: 10.1002/ppul.24993.
RECOMMENDED
ARDS
Lung Recruitment in Obese Patients with Acute Respiratory Distress Syndrome
Anesthesiology.
Fumagalli J, Santiago RRS, Teggia Droghi M, Zhang C, Fintelmann FJ, Troschel FM, Morais CCA, Amato MBP, Kacmarek RM, Berra L, Lung Rescue Team Investigators
doi: 10.1097/ALN.
Higher PEEP versus Lower PEEP Strategies for Patients with Acute Respiratory Distress Syndrome. A Systematic Review and Meta-Analysis
Ann Am Thorac Soc.
Walkey AJ, Del Sorbo L, Hodgson CL, Adhikari NKJ, Wunsch H, Meade MO, Uleryk E, Hess D, Talmor DS, Thompson BT, Brower RG, Fan E
doi: 10.1513/AnnalsATS.201704-
RECOMMENDED
ARDS
Maximal Recruitment Open Lung Ventilation in Acute Respiratory Distress Syndrome (PHARLAP): A Phase II, Multicenter, Randomized, Controlled Trial
Am J Respir Crit Care Med.
Hodgson CL, Cooper DJ, Arabi Y, King V, Bersten A, Bihari S, Brickell K, Davies A, Fahey C, Fraser J, McGuinness S, Murray L, Parke R, Paul E, Tuxen D, Vallance S, Young M, Nichol A, PHARLAP Study Investigators and the ANZICS Clinical Trials Group.
doi: 10.1164/rccm.201901-0109OC.
RECOMMENDED
ARDS
Effect of Dexamethasone on Days Alive and Ventilator-Free in Patients With Moderate or Severe Acute Respiratory Distress Syndrome and COVID-19: The CoDEX Randomized Clinical Trial
★ 2
Recommended by
Dr Martin Frey, Faculty Member
JAMA.
Tomazini BM, Maia IS, Cavalcanti AB, Berwanger O, Rosa RG, Veiga VC, Avezum A, Lopes RD, Bueno FR, Silva MVAO, Baldassare FP, Costa ELV, Moura RAB, Honorato MO, Costa AN, Damiani LP, Lisboa T, Kawano-Dourado L, Zampieri FG, Olivato GB, Righy C, Amendola CP, Roepke RML, Freitas DHM, Forte DN, Freitas FGR, Fernandes CCF, Melro LMG, Junior GFS, Morais DC, Zung S, Machado FR, Azevedo LCP, COALITION COVID-19 Brazil III Investigators
doi: 10.1001/jama.2020.17021.
ARDS
An Open Lung Strategy in the Management of Acute Respiratory Distress Syndrome: A systematic review and meta-analysis.
Shock.
Lu J, Wang X, Chen M, Cheng L, Chen Q, Jiang H, Sun Z
doi: 10.1097/
RECOMMENDED
ARDS
Low to Moderate Air Pollutant Exposure and Acute Respiratory Distress Syndrome after Severe Trauma
Am J Respir Crit Care Med.
Reilly JP, Zhao Z, Shashaty MGS, Koyama T, Christie JD, Lanken PN, Wang C, Balmes JR, Matthay MA, Calfee CS, Ware LB
doi: 10.1164/rccm.201803-0435OC.
ARDS
Paediatric acute respiratory distress syndrome incidence and epidemiology (PARDIE): an international, observational study
Lancet Respir Med.
Khemani RG, Smith L, Lopez-Fernandez YM, Kwok J, Morzov R, Klein MJ, Yehya N, Willson D, Kneyber MCJ, Lillie J, Fernandez A, Newth CJL, Jouvet P, Thomas NJ; Pediatric Acute Respiratory Distress syndrome Incidence and Epidemiology (PARDIE) Investigators; Pediatric Acute Lung Injury and Sepsis Investigators (PALISI) Network
doi: 10.1016/S2213-2600
ARDS
Treatment with allogeneic mesenchymal stromal cells for moderate to severe acute respiratory distress syndrome (START study): a randomised phase 2a safety trial
Lancet Respir Med.
Matthay MA, Calfee CS, Zhuo H, Thompson BT, Wilson JG, Levitt JE, Rogers AJ, Gotts JE, Wiener-Kronish JP, Bajwa EK, Donahoe MP, McVerry BJ, Ortiz LA, Exline M, Christman JW, Abbott J, Delucchi KL, Caballero L, McMillan M, McKenna DH, Liu KD
doi: 10.1016/S2213-2600(18)30418-1.